Pernix Therapeutics Holdings is a specialty pharmaceutical company chiefly focused on selling, marketing, and developing branded and generic pharmaceutical products. The company manages an array of both branded and generic products and is currently developing Theobromine, a non-codeine cough suppressant product candidate. Pernix Therapeutics’ branded pediatrics products include a middle-ear infection antibiotic, a topical treatment for head lice, and a family of prescription cough and cold treatments. For more information, visit the company’s Web site at www.pernixtx.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: